Applied Biomics
Private Company
Funding information not available
Overview
Applied Biomics is a well-established, private contract research organization (CRO) focused on providing high-quality proteomics services. Its core technology platform centers on advanced 2D Differential Gel Electrophoresis (2D DIGE) and mass spectrometry, which it applies to biomarker discovery, post-translational modification analysis, and critical quality control for biopharmaceuticals like Host Cell Protein (HCP) profiling. With over 30 years of collective experience, 450+ featured publications, and all services performed in-house, the company has built a strong reputation for reliability and technical expertise in a niche but essential segment of the life sciences tools market.
Technology Platform
Centered on advanced 2D Differential Gel Electrophoresis (2D DIGE) complemented by high-resolution mass spectrometry (nanoLC-MS/MS) and specialized 2D Western Blot. Platforms are optimized for full proteome profiling, quantitative differential analysis, post-translational modification (PTM) discovery, and high-sensitivity Host Cell Protein (HCP) analysis for biopharma.
Opportunities
Risk Factors
Competitive Landscape
Competes in the proteomics services market against large global CROs (e.g., Charles River Laboratories, LabCorp's Covance), university core facilities, and specialized MS service providers. Its differentiation lies in its expertise and unique offerings in 2D DIGE and integrated 2D Western Blot for PTMs, as well as its specialized, high-coverage HCP analysis platform, which claims advantages in visualization and antibody coverage assessment.